Implications of the Medicare Prescription Drug Benefit for Dual Eligibles and State Medicaid Programs PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Implications of the Medicare Prescription Drug Benefit for Dual Eligibles and State Medicaid Programs PDF full book. Access full book title Implications of the Medicare Prescription Drug Benefit for Dual Eligibles and State Medicaid Programs by Karen Tritz. Download full books in PDF and EPUB format.
Author: Karen Tritz
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 6
Get Book Here
Book Description
Author: Karen Tritz
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 6
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA, P.L. 108-173), enacted in December 2003, will have a significant effect on Medicaid beneficiaries who also have Medicare coverage (i.e., "dual eligibles") and on state Medicaid programs. This report highlights several provisions affecting dual eligible beneficiaries and state Medicaid programs and describes some of the areas where significant questions remain. This report will be updated.
Author: United States Government Accountability Office
Publisher: Createspace Independent Publishing Platform
ISBN: 9781976386305
Category :
Languages : en
Pages : 72
Get Book Here
Book Description
Since January 1, 2006, all dual-eligible beneficiaries-individuals with both Medicare and Medicaid coverage-must receive their drug benefit through Medicare's new Part D prescription drug plans (PDP) rather than from state Medicaid programs. GAO analyzed (1) current challenges in identifying and enrolling new dual-eligible beneficiaries in PDPs, (2) the Centers for Medicare & Medicaid Services' (CMS) efforts to address challenges, and (3) federal and state approaches to assigning dual-eligible beneficiaries to PDPs. GAO reviewed federal law, CMS regulations and guidance and interviewed CMS and PDP officials, among others. GAO also made site visits to six states to learn about the enrollment of dual-eligible beneficiaries from the state perspective.
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA, P.L. 108-173) made several major changes to Medicare including (1) adding a voluntary Medicare Part D outpatient prescription drug benefit effective January 1, 2006; (2) offering Medicare beneficiaries discounted prescription drugs in 2004 and 2005 through an endorsed discount card; (3) modifying various Medicare payment rates. The new Medicare drug benefit is funded in two ways: (1) by traditional Medicare funding through enrollee payments and the Health Insurance Trust Fund; and (2) by phased-down (commonly referred to as “clawbackâ€ŗ) payments from the states to the federal government. The state payments reflect the fact that starting in 2006, Medicare Part D will replace the prescription drug benefits currently received by dual eligibles (individuals enrolled in both Medicaid and Medicare) through state Medicaid programs. The funding mechanism for the new Medicare prescription drug benefit has the potential to reduce both Medicaid and other state health expenditures. However, two types of issues associated with the financing of Part D may affect the potential for state budget savings: (1) technical issues associated with the formula for calculating phased-down state payments to the federal government; and (2) policy issues raised by MMA that may directly or indirectly impact Medicaid and other state health programs. This report outlines the issues associated with the financing of Part D coverage through phased-down state payments to the federal government, as well as the potential impacts of the Medicare drug benefit on Medicaid and other state health expenditures. It will not be updated.
Author: Leslie G. Aronovitz (au)
Publisher: DIANE Publishing
ISBN: 9781422306734
Category : Business & Economics
Languages : en
Pages : 88
Get Book Here
Book Description
On Jan. 1, 2006, Medicare began providing coverage for outpatient prescription drugs through its new Part D benefit. Beneficiaries who enroll in Part D may choose a drug plan from those offered by private plan sponsors under contract to the Centers for Medicare & Medicaid Serv. (CMS), which administers the Part D benefit. Beneficiaries have until May 15, 2006, to enroll in the Part D benefit & select a plan without the risk of penalties. This report reviews the quality of CMS's commun. on the Part D benefit. This report: examined 70 CMS publications to select 6 documents to review & evaluate the clarity of these texts; made 500 calls to the 1-800-MEDICARE help line; & evaluated the usability of the Medicare Web site. Illus.
Author: United States. Congress. Senate. Committee on Finance
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 310
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 76
Get Book Here
Book Description
Author: Anirban Basu
Publisher:
ISBN:
Category : Elderly poor
Languages : en
Pages :
Get Book Here
Book Description
Features of Part D gave rise to broad concern that the drug benefit would negatively impact prescription utilization among the six million dual eligible beneficiaries, either during the transition from state Medicaid to Part D coverage, or in the long-run. At the same time, Part D contained other features, such as its auto-enrollment and premium subsidization policies, which were designed to safeguard utilization for this vulnerable group. Using national retail pharmacy claims, we examine the experience of dual eligibles during the first 18 months of Part D. We find no evidence that Part D adversely affected pharmaceutical utilization or out-of-pocket expenditures in the transition period, or in the 18 months subsequent to Part D implementation.
Author: United States. Congress. Senate. Committee on Finance
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 204
Get Book Here
Book Description
Author: United States. Congress. House. Committee on Ways and Means. Subcommittee on Health
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 232
Get Book Here
Book Description
